Arkolith/Insider Trading/KYMR/Form 4

Mainolfi Nello

Chief Executive Officer, DirectorKymera Therapeutics, Inc. (KYMR) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.0M
Net Open-Market Flow
-$6.0M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)50K$2.08$104K717K
Jul 7, 2026Sell(S)50K$119.00$6.0M667K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)46K—$090K
Jul 7, 2026Option exercise(M)4K—$014K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-297817) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML